Skip to main content
. 2011 Mar;13(1):127–138. doi: 10.31887/DCNS.2011.13.1/rjoffe

Table V. Antidepressant augmentation with T4. T3, tri-iodothyronine; T4, thyroxine; RCT, randomized controlled trial; SSRI, selective serotonin reuptake inhibitor.

Study N Patients T4 Dose (µg/day) Design Response
Joffe and Singer, 199036 38 Unipolar major depression 150 Double-blind vs T3 4 of 21 responded to T4, T4 < T3
Bauer et al, 199848 17 Unipolar (or) bipolar depression 300-500 Open 10 of 17 showed full or partial response
Spoov and Lahdelma, 199849 22 Major depression 200 Crossover vs lithium T4 > lithium
Rudas et al, 199950 9 Chronic depression and dysthymia 150-300 Open 6 of 9 full or partial response
Lojko and Rybakowski, 200751 17 Unipolar and bipolar depression 100 Open, on SSRI 11 remission and 16 response